Selpercatinib + Cyp3a Inducers Interaction

Moderateinteraction on record

Description

Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministration.

Mechanism

CYP3A induction decreases selpercatinib plasma concentrations

Source: NLP:selpercatinib